Advertisement

Topics

Berlin Pharmaceutical Industry Co., Ltd Company Profile

03:40 EDT 25th June 2018 | BioPortfolio


News Articles [951 Associated News Articles listed on BioPortfolio]

Jin Jiang International mit allen wichtigen Marken auf ITB Berlin vertreten

Die erste ITB Berlin fand 1966 statt. ITB Berlin hat sich in ihrer 50-jährigen Geschichte nicht nur als führende Fachmesse der internationalen Tourismus-Wirtschaft etabliert, sie Read more...

Berlin responds to crayfish plague: If you can't beat them, eat them

BERLIN (Reuters) - North American crayfish that spilled en masse onto Berlin streets last summer will soon be appearing in the city's restaurants after its government authorized fishermen to remove th...

Jin Jiang International participe à la 52e édition du salon ITB Berlin avec toutes ses ...

La première édition d'ITB Berlin a eu lieu en 1966. ITB Berlin n'est pas seulement un salon international précurseur pour l'industrie touristique mondiale, mais aussi Read more...

MPH-Aktie: Deutliche Steigerung der Dividende - Kaufempfehlung, Kursziel erhöht

Berlin (www.aktiencheck.de) - MPH-Aktienanalyse von Aktienanalyst Ellis Acklin von First Berlin: Ellis Acklin, Aktienanalyst von First Berlin, rät in einer aktuellen Aktienanalyse weiterhin zum Kau.....

Valneva-Aktie: Vielversprechende Top-Line-Daten zu VLA15 - Kaufempfehlung, Kursziel erhöht

Berlin - Valneva-Aktienanalyse von Aktienanalyst Christian Orquera von First Berlin: Christian Orquera, Aktienanalyst von First Berlin, bestätigt in einer aktuellen Aktienanalyse seine Kaufempfehlu.....

Tauriga Sciences Inc. to Present at European Institutional Investor Conference on June 21, 2018 in Berlin, Germany; Venue is the Representative Office of Baden-Wurttemberg in Berlin 

NEW YORK, NY, April 25, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, a...

Could block chain be the salvation of the pharmaceutical industry?

When applied to the pharmaceutical industry, and more specifically to clinical trials, the interest of block chain technology seems obvious. Currently 53% of the population doesn't trust the pharm...

Epigenomics-Aktie: Ungewissheit bezüglich der Rückerstattung von Epi proColon - Kursziel gekappt

Berlin - Epigenomics-Aktienanalyse von Aktienanalyst Simon Scholes von First Berlin: Simon Scholes, Aktienanalyst von First Berlin, rät in einer aktuellen Aktienanalyse die Aktie des Molekulardiagn.....

PubMed Articles [885 Associated PubMed Articles listed on BioPortfolio]

Applications of proteomics in pharmaceutical research and development.

The significance of proteomics in the pharmaceutical industry has increased since overcoming initial difficulties. This review discusses recent proteomics publications from pharmaceutical companies to...

Controversies Surrounding Authorship of Manuscripts by Industry Employees: Academic and Industry Perspectives.

The medical device and pharmaceutical industries play an essential role in the development of cardiovascular devices and drugs, and industry employees are frequently listed as co-authors of clinical t...

Pharmaceutical cocrystallization techniques. Advances and challenges.

Cocrystals are homogenous (single-phase) crystalline structures composed by two or more components in a definite stoichiometric ratio bonded together by noncovalent bonds. Pharmaceutical industry has ...

Melt extrusion with poorly soluble drugs - An integrated review.

Over the last few decades, hot melt extrusion (HME) has emerged as a successful technology for a broad spectrum of applications in the pharmaceutical industry. As indicated by multiple publications an...

Pharmacokinetics and Drug Metabolism in Canada: The Current Landscape-A Summary of This Indispensable Special Issue.

Canadian Pharmaceutical Scientists have a rich history of groundbreaking research in pharmacokinetics and drug metabolism undertaken primarily throughout its Pharmacy Faculties and within the Pharmace...

Clinical Trials [441 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Daclatasvir From Prodactariv 60 mg Film Coated Tablets (International Drug Agency for Pharmaceutical Industry (IDI), Egypt) and Clatazev 60 mg Tablets (Bristol-Myers Squibb Pharma, UK)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Daclatasvir from Prodactariv 60 mg F.C.T (International Drug Agency for Pha...

Biomarker Development for Postoperative Cognitive Impairment in the Elderly (BioCog)

The research leading consortium to these results has received funding from the European Union Seventh Framework Programme [FP7/2007-2013] under grant agreement no 602461 (www.biocog.eu). ...

Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...

Improving Compliance Among Elderly Polypharmacy Users Through Community Pharmacy Based Pharmaceutical Care Program

The aim of the project is to evaluate effectiveness of a multidimensional pharmaceutical care plan in improving compliance among elderly polypharmacy users at community pharmacy settings. ...

Companies [2376 Associated Companies listed on BioPortfolio]

BERLIN-CHEMIE AG

BERLIN-CHEMIE develops, produces and markets pharmaceutical products. BERLIN-CHEMIE AG is part of the global MENARINI GROUP, which is headquartered in Florence/Italy. MENARINI is the largest Italian p...

Berlin Partner GmbH

Berlin Partner, the official economic development agency for the city of Berlin, Germany, partners with companies, providing one-stop service and support for companies considering...

Berlin Pharmaceutical Industry Co., Ltd

Berlin Heart AG

Berlin - a city with a heart for new scientific developments, the birthplace of German VAD (ventricular assist device) technology. Without doubt, one of the pioneering achievements in this city was a ...

Berlin Heart,Inc

In 1997 the acquisition of the paracoporeal device with the name"Berlin Heart" from the company Fehling Medical AG took place the Mediport Berlin Heart Gmbh Kardiotechnik Was Founded.In order to make ...

More Information about "Berlin Pharmaceutical Industry Co., Ltd" on BioPortfolio

We have published hundreds of Berlin Pharmaceutical Industry Co., Ltd news stories on BioPortfolio along with dozens of Berlin Pharmaceutical Industry Co., Ltd Clinical Trials and PubMed Articles about Berlin Pharmaceutical Industry Co., Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Berlin Pharmaceutical Industry Co., Ltd Companies in our database. You can also find out about relevant Berlin Pharmaceutical Industry Co., Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record